Clinical Trial Update: OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes

View source ↗

Summary

This entry describes a clinical trial named OPTImaL investigating optimized treatment for patients with early-stage triple-negative breast cancer with high stro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Breast Cancer Stage I, Triple Negative Breast Cancer (TNBC) | Status: RECRUITING